Autoantibody Levels in Autoimmune Pancreatitis Patients for Disease Monitoring

Supplementary material from a study correlating autoantibody levels with disease activity in autoimmune pancreatitis. The study analyzed 55 patients from the University Medical Centre Mannheim and examined 769 treatment appointments. The data was uploaded by figshare admin karger and last updated in April 2026.

Use Cases

• Predicting relapse risk based on baseline autoantibody levels and their reduction after corticosteroid treatment.
• Monitoring disease activity by correlating autoantibody titers with clinical markers like AiP Activity-Score and organ involvement.
• Investigating associations between specific autoantibodies (e.g., rheumatoid factor, ANCA) and disease subtypes (AiP type 1 vs. type 2).
• Analyzing the relationship between autoantibody presence and specific clinical presentations, such as focal mass or inflammatory bowel disease.

Strengths

• Data is derived from a clinical study of 55 patients, providing a focused cohort.
• Analysis includes 769 treatment appointments, offering multiple observations per patient.
• Correlations are investigated with specific clinical parameters like disease severity and relapse risk.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect geographic bias inherent to a single medical center in Germany.

Provenance

Source

University Medical Centre Mannheim (Germany)

Collection Method

Clinical study analyzing patient appointments.

Freshness

Last updated 2026-04-10 09:55:11; freshness should be verified.

Geography

Germany